Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes
Kelly Doolin(Trinity College Dublin), Veronica O’Keane(Trinity College Dublin), Sina Pleiner(Boehringer Ingelheim (Germany)), Thomas Frodl(University of Southern California), Leonardo Tozzi(Stanford University), Erik O’Hanlon(Royal College of Surgeons in Ireland), Kelly A. Allers(Boehringer Ingelheim (Germany)), André Liesener(Boehringer Ingelheim (Germany)), Darren Roddy(University College Dublin), Chloë Farrell(Trinity College Dublin), Andrew Harkin(Trinity College Dublin)
Cited by 90
Related Papers
Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
|Molecular Psychiatry|2015|1.2k
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|682
White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group
|Molecular Psychiatry|2019|372
The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression
|Biological Psychiatry|2018|279
ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing
|Translational Psychiatry|2020|237